{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:09:00Z","timestamp":1791493740362,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007210","name":"Varian Medical Systems","doi-asserted-by":"publisher","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}],"id":[{"id":"10.13039\/100007210","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014584","name":"Universit\u00e4tsmedizin der Johannes Gutenberg-Universit\u00e4t Mainz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014584","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>About one fifth of patients with head and neck cancer are aged 70\u00a0years and older at the time of diagnosis. In these patients, risk factors (R1 status or extracapsular extension of lymph node metastases, ECE) often lead to a\u00a0need for combined chemoradiotherapy (CRT) in the postoperative setting. However, there is considerable concern about the toxicity of such therapy in this age group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Retrospective evaluation of the data of 53\u00a0patients \u2265\u202f70\u00a0years of age who underwent surgery in our hospital between 1999 and 2015 for tumors of the oral cavity, the oropharynx, the hypopharynx, or the larynx, who subsequently received adjuvant radiation therapy. Two younger patients (&lt;\u202f70\u00a0years) were assigned to each of the elderly patients in a\u00a0matching procedure based on anatomic sublocalization and tumor stage. The total cohort was comprised of 154 patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Univariate analyses revealed a\u00a0statistically significant influence of many factors on overall survival (OS) and progression-free survival (PFS), including Karnofsky performance score (KPS), alcohol consumption, smoking, R\u00a0status, ECE, chemotherapy, and discontinuation of RT. Younger patients had better OS and PFS compared to the elderly (<jats:italic>p<\/jats:italic>\u202f=\u20090.013 and 0.012, respectively). In a\u00a0multivariate Cox regression, no independent influence of age on OS and PFS was found. Survival was primarily dependent on the addition of chemotherapy to radiotherapy (RT), application of the full course of RT, continued alcohol abuse, KPS, and the presence of ECE. Toxicity analysis showed a\u00a0higher incidence of chronic renal failure but, generally, side effects for elderly patients were not substantially greater.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Performance status and behavioral risk factors but not chronological age are crucial for the prognosis of patients who require adjuvant chemoradiation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00066-021-01890-2","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T15:03:55Z","timestamp":1642431835000},"page":"159-170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Adjuvant chemoradiotherapy in elderly patients with head and neck cancer: a\u00a0monoinstitutional, two-to-one pair-matching analysis"],"prefix":"10.1007","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3101-9180","authenticated-orcid":false,"given":"Arnulf","family":"Mayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witali","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wollschl\u00e4ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Bostel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Matthias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Schmidberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"1890_CR1","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1001\/archotol.130.2.161","volume":"130","author":"M Airoldi","year":"2004","unstructured":"Airoldi\u00a0M, Cortesina\u00a0G, Giordano\u00a0C et\u00a0al (2004) Postoperative adjuvant chemoradiotherapy in older patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 130:161\u2013166","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"1890_CR2","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1002\/hed.20279","volume":"27","author":"J Bernier","year":"2005","unstructured":"Bernier\u00a0J, Cooper\u00a0JS, Pajak\u00a0TF et\u00a0al (2005) Defining risk levels in locally advanced head and neck cancers: a\u00a0comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 27:843\u2013850","journal-title":"Head Neck"},{"key":"1890_CR3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1056\/NEJMoa032641","volume":"350","author":"J Bernier","year":"2004","unstructured":"Bernier\u00a0J, Domenge\u00a0C, Ozsahin\u00a0M et\u00a0al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N\u00a0Engl J Med 350:1945\u20131952","journal-title":"N Engl J Med"},{"key":"1890_CR4","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMoa053422","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner\u00a0JA, Harari\u00a0PM, Giralt\u00a0J et al (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N\u00a0Engl J Med 354:567\u2013578","journal-title":"N Engl J Med"},{"key":"1890_CR5","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.oraloncology.2018.07.012","volume":"84","author":"MM Chen","year":"2018","unstructured":"Chen\u00a0MM, Colevas\u00a0AD, Megwalu\u00a0U et al (2018) Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age. Oral Oncol 84:71\u201375","journal-title":"Oral Oncol"},{"key":"1890_CR6","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1056\/NEJMoa032646","volume":"350","author":"JS Cooper","year":"2004","unstructured":"Cooper\u00a0JS, Pajak\u00a0TF, Forastiere\u00a0AA et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N\u00a0Engl J Med 350:1937\u20131944","journal-title":"N Engl J Med"},{"key":"1890_CR7","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/hed.21022","volume":"31","author":"JS Cooper","year":"2009","unstructured":"Cooper\u00a0JS, Porter\u00a0K, Mallin\u00a0K et al (2009) National cancer database report on cancer of the head and neck: 10-year update. Head Neck 31:748\u2013758","journal-title":"Head Neck"},{"key":"1890_CR8","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.ijrobp.2012.05.008","volume":"84","author":"JS Cooper","year":"2012","unstructured":"Cooper\u00a0JS, Zhang\u00a0Q, Pajak\u00a0TF et al (2012) Long-term follow-up of the RTOG 9501\/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 84:1198\u20131205","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1890_CR9","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/lary.26798","volume":"128","author":"NJ Giacalone","year":"2018","unstructured":"Giacalone\u00a0NJ, Qureshi\u00a0MM, Mak\u00a0KS et al (2018) Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer. Laryngoscope 128:831\u2013840","journal-title":"Laryngoscope"},{"key":"1890_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13014-020-1481-z","volume":"15","author":"E Haehl","year":"2020","unstructured":"Haehl\u00a0E, Ruhle\u00a0A, David\u00a0H et al (2020) Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly? Radiat Oncol 15:31","journal-title":"Radiat Oncol"},{"key":"1890_CR11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/0360-3016(94)E0297-W","volume":"31","author":"PM Harari","year":"1995","unstructured":"Harari\u00a0PM, O\u2019connor\u00a0NJ, Fiore\u00a0MC et\u00a0al (1995) Radiation oncologists can assist head and neck cancer patients with smoking cessation. Int J Radiat Oncol Biol Phys 31:645\u2013649","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1890_CR12","volume-title":"Survminer: drawing survival curves using \u201cggplot2\u201d","author":"A Kassambara","year":"2020","unstructured":"Kassambara\u00a0A, Kosinski\u00a0M, Biecek\u00a0P (2020) Survminer: drawing survival curves using \u201cggplot2\u201d"},{"key":"1890_CR13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00066-020-01621-z","volume":"196","author":"EM Kretschmer","year":"2020","unstructured":"Kretschmer\u00a0EM, Pavic\u00a0M, Stark\u00a0LS et al (2020) Radiotherapy of the oldest old-feasibility and institutional analysis. Strahlenther Onkol 196:683\u2013690","journal-title":"Strahlenther Onkol"},{"key":"1890_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s00066-012-0125-0","volume":"188","author":"NP Nguyen","year":"2012","unstructured":"Nguyen\u00a0NP, Vock\u00a0J, Chi\u00a0A et al (2012) Impact of intensity-modulated and image-guided radiotherapy on elderly patients undergoing chemoradiation for locally advanced head and neck cancer. Strahlenther Onkol 188:677\u2013683","journal-title":"Strahlenther Onkol"},{"key":"1890_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","volume":"92","author":"JP Pignon","year":"2009","unstructured":"Pignon\u00a0JP, le Maitre\u00a0A, Maillard\u00a0E et al (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346\u00a0patients. Radiother Oncol 92:4\u201314","journal-title":"Radiother Oncol"},{"key":"1890_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","volume":"17","author":"M Schemper","year":"1996","unstructured":"Schemper\u00a0M, Smith\u00a0TL (1996) A note on quantifying follow-up in studies of failure time. Control Clin Trials 17:343\u2013346","journal-title":"Control Clin Trials"},{"key":"1890_CR17","volume-title":"gtsummary: presentation-ready data summary and analytic result tables","author":"DD Sjoberg","year":"2021","unstructured":"Sjoberg\u00a0DD, Curry\u00a0M, Hannum\u00a0M et al (2021) gtsummary: presentation-ready data summary and analytic result tables"},{"key":"1890_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1758-3284-2-22","volume":"2","author":"JL St Guily","year":"2010","unstructured":"St Guily\u00a0JL, Borget\u00a0I, Vainchtock\u00a0A et\u00a0al (2010) Head and neck cancers in France: an analysis of the hospital medical information system (PMSI) database. Head Neck Oncol 2:22","journal-title":"Head Neck Oncol"},{"key":"1890_CR19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/MOO.0000000000000526","volume":"27","author":"P Szturz","year":"2019","unstructured":"Szturz\u00a0P, Bossi\u00a0P, Vermorken\u00a0JB (2019) Systemic treatment in elderly head and neck cancer patients: recommendations for clinical practice. Curr Opin Otolaryngol Head Neck Surg 27:142\u2013150","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"1890_CR20","unstructured":"The jamovi project (2021). jamovi (Version 1.6.13.0) [Computer Software]. Retrieved from https:\/\/www.jamovi.org"},{"key":"1890_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: extending the Cox model","author":"TM Therneau","year":"2000","unstructured":"Therneau\u00a0TM, Grambsch\u00a0PM (2000) Modeling survival data: extending the Cox model"},{"key":"1890_CR22","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1200\/JCO.2016.68.2336","volume":"35","author":"DM Trifiletti","year":"2017","unstructured":"Trifiletti\u00a0DM, Smith\u00a0A, Mitra\u00a0N et\u00a0al (2017) Beyond positive margins and extracapsular extension: evaluating the utilization and clinical impact of postoperative chemoradiotherapy in resected locally advanced head and neck cancer. J\u00a0Clin Oncol 35:1550\u20131560","journal-title":"J Clin Oncol"},{"key":"1890_CR23","volume-title":"\u00dcberleben ICD-10 C00-C14: HNO-Tumoren","author":"Tumorregister M\u00fcnchen","year":"2020","unstructured":"Tumorregister M\u00fcnchen (2020) \u00dcberleben ICD-10 C00-C14: HNO-Tumoren"},{"key":"1890_CR24","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.ijrobp.2017.03.019","volume":"98","author":"NM Woody","year":"2017","unstructured":"Woody\u00a0NM, Ward\u00a0MC, Koyfman\u00a0SA et al (2017) Adjuvant chemoradiation after surgical resection in elderly patients with high-risk squamous cell carcinoma of the head and neck: a national cancer database analysis. Int J Radiat Oncol Biol Phys 98:784\u2013792","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1890_CR25","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/hed.25100","volume":"40","author":"EJ Yoshida","year":"2018","unstructured":"Yoshida\u00a0EJ, Luu\u00a0M, David\u00a0JM et\u00a0al (2018) Postoperative chemoradiotherapy in patients with head and neck cancer aged 70 or older with positive margins or extranodal extension and the influence of nodal classification. Head Neck 40:1228\u20131236","journal-title":"Head Neck"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-021-01890-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-021-01890-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-021-01890-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T13:06:00Z","timestamp":1643115960000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-021-01890-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1890"],"URL":"https:\/\/doi.org\/10.1007\/s00066-021-01890-2","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]},"assertion":[{"value":"10 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.\u00a0Mayer, W.\u00a0Wenzel, D.\u00a0Wollschl\u00e4ger, T.\u00a0Bostel, M.\u00a0Kr\u00fcger, C.\u00a0Matthias, and H.\u00a0Schmidberger declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"In this study, only data collected as part of regular clinical diagnostics and therapy at our hospital were used for scientific evaluation. Additional study-related measures were not performed. All data were used in anonymized form only. Under these conditions, according to the laws of the state of Rhineland-Palatinate (<i>Landeskrankenhausgesetz<\/i>, \u00a7\u00a036 and \u00a7\u00a037), no vote of the ethics committee and no separate consent of the patients are required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}